These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16533162

  • 1. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.
    Tai HH, Cho H, Tong M, Ding Y.
    Curr Pharm Des; 2006; 12(8):955-62. PubMed ID: 16533162
    [Abstract] [Full Text] [Related]

  • 2. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
    Cho H, Huang L, Hamza A, Gao D, Zhan CG, Tai HH.
    Bioorg Med Chem; 2006 Oct 01; 14(19):6486-91. PubMed ID: 16828555
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.
    Cho H, Hamza A, Zhan CG, Tai HH.
    Arch Biochem Biophys; 2005 Jan 15; 433(2):447-53. PubMed ID: 15581601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Critical residues for the coenzyme specificity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Cho H, Oliveira MA, Tai HH.
    Arch Biochem Biophys; 2003 Nov 15; 419(2):139-46. PubMed ID: 14592457
    [Abstract] [Full Text] [Related]

  • 9. 15-Hydroxyprostaglandin dehydrogenase.
    Ensor CM, Tai HH.
    J Lipid Mediat Cell Signal; 1995 Oct 15; 12(2-3):313-9. PubMed ID: 8777575
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH.
    Cancer Metastasis Rev; 2011 Dec 15; 30(3-4):409-17. PubMed ID: 22020925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH, Chi X, Tong M.
    Prostaglandins Other Lipid Mediat; 2011 Nov 15; 96(1-4):37-40. PubMed ID: 21763448
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Zhou H, Tai HH.
    Biochem Biophys Res Commun; 1999 Apr 13; 257(2):414-7. PubMed ID: 10198228
    [Abstract] [Full Text] [Related]

  • 17. Threonine 11 of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD(+) during catalysis.
    Cho H, Tai HH.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr 13; 66(5-6):505-9. PubMed ID: 12144871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    Yao L, Chen W, Song K, Han C, Gandhi CR, Lim K, Wu T.
    PLoS One; 2017 Apr 13; 12(4):e0176106. PubMed ID: 28423012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.